Pierre Gravier serves as Executive at PTC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Pierre Gravier has executed 7 insider transactions totaling $565.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 6, 2026 involved selling 2,139 shares valued at $164.6K.
Pierre Gravier currently holds 90,310 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pierre Gravier has been a net seller of PTCT stock. They have purchased $198.7K and sold $366.2K worth of shares.
Pierre Gravier's most recent insider trade was on Jan 6, 2026, when they sold 2,139 shares at $76.95 per share.
Get notified when new Form 4 filings are submitted
| $49.46 |
| Discretionary |
| Jul 16, 2024 | PTCT | $77.2K | Sale | 2,269 | $34.02 | Planned |
| Feb 15, 2024 | PTCT | $0 | Award | 3,100 | $N/A | Discretionary |
| Feb 15, 2024 | PTCT | $0 | Award | 19,000 | $N/A | Discretionary |
| Dec 12, 2023 | PTCT | $198.7K | Purchase | 7,700 | $25.81 | Discretionary |
| Jul 13, 2023 | PTCT | $0 | Award | 26,000 | $N/A | Discretionary |